Evidence map›Paper›PMID 27775687›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2016

Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase C.

Hiroaki Iwata, Mayumi Kamaguchi, Hideyuki Ujiie, Machiko Nishimura, Kentaro Izumi, Ken Natsuga, Satoru Shinkuma, Wataru Nishie, Hiroshi Shimizu

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. EGF-Induced Macropinocytosis Promotes NAV1-Dependent Internalization of Occludin in Keratinocytes.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. BP180/Collagen XVII: A Molecular View.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Resolution in bullous pemphigoid.Seminars in immunopathology · 2019
    Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hiroaki IwataDepartment of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Mayumi KamaguchiDepartment of Oral Diagnosis and Medicine Hokkaido University, Graduate School of Dental Medicine, Sapporo, Japan.
Hideyuki UjiieDepartment of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Machiko NishimuraDepartment of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Kentaro IzumiDepartment of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Ken NatsugaDepartment of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Satoru ShinkumaDepartment of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Wataru NishieDepartment of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Hiroshi ShimizuDepartment of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Hokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macropinocytosis is an endocytic pathway that is involved in the nonselective fluid uptake of extracellular fluid. Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with autoantibodies to type XVII collagen (COL17), which is a component of hemidesmosome. When keratinocytes are treated with BP-IgG, COL17 internalizes into cells by way of the macropinocytosis. We investigated the mechanism of COL17 macropinocytosis using DJM-1 cells, a cutaneous squamous cell carcinoma cell line. First, non-hemidesmosomal COL17 was preferentially depleted by stimulation with the BP-IgG in the DJM-1 cells. To investigate the signaling involved in COL17-macropinocytosis, the inhibition of small GTPase family members Rac1 and Cdc42 was found to strongly repress COL17 internalization; in addition, the Rho inhibitor also partially blocked that internalization, suggesting these small GTPases are involved in signaling to mediate COL17-macropinocytosis. Western blotting using Phostag-SDS-PAGE demonstrated high levels of COL17 phosphorylation in DJM-1 cells under steady-state condition. Treatment with BP-IgG increased the intracellular calcium level within a minute, and induced the overabundant phosphorylation of COL17. The overabundant phosphorylation of COL17 was suppressed by a protein kinase C (PKC) inhibitor. In addition, PKC inhibitor repressed COL17 endocytosis using cell culture and organ culture systems. Finally, the depletion of COL17 was not observed in the HEK293 cells transfected COL17 without intracellular domain. These results suggest that COL17 internalization induced by BP-IgG may be mediated by a PKC pathway. In summary, BP-IgG initially binds to COL17 distributed on the plasma membrane, and COL17 may be internalized by means of a macropinocytic pathway related to the phosphorylation of the intracellular domain by PKC.

Indexed as

AnimalsAntibodies, MonoclonalAutoantibodiesAutoantigensCalcium SignalingCell Line, TumorCollagen Type XVIIHEK293 CellsHumansImmunoglobulin GKeratinocytesMiceNon-Fibrillar CollagensPemphigoid, BullousPeptide FragmentsPhosphorylationAntibodies, MonoclonalAutoantibodiesAutoantigensCollagen Type XVIIImmunoglobulin GNon-Fibrillar CollagensPeptide FragmentsProtein Kinase CProtein Kinase InhibitorsRecombinant Proteins

Identifiers

PMID27775687
OpenAlexW2535184234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.